e-therapeutics plc
ETXPF
$0.13
-$0.01-7.14%
OTC PK
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.27M | 25.06M | 31.96M | 31.23M | 39.04M |
| Total Receivables | 597.60K | 570.00K | 388.40K | 379.70K | 319.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 640.80K | 611.30K | 832.20K | 813.40K | 681.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.46M | 2.35M | 3.26M | 3.19M | 1.85M |
| Total Current Assets | 29.97M | 28.59M | 36.44M | 35.62M | 41.88M |
|
|
|||||
| Total Current Assets | 29.97M | 28.59M | 36.44M | 35.62M | 41.88M |
| Net Property, Plant & Equipment | 1.26M | 1.20M | 225.10K | 220.00K | 492.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 517.50K | 493.60K | 387.20K | 378.40K | 294.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 31.75M | 30.28M | 37.05M | 36.21M | 42.67M |
|
|
|||||
| Total Accounts Payable | 1.38M | 1.32M | 1.53M | 1.49M | 528.40K |
| Total Accrued Expenses | 1.24M | 1.18M | -- | -- | 835.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 499.70K | 476.60K | 115.80K | 113.10K | 363.40K |
| Total Finance Division Other Current Liabilities | 260.60K | 248.60K | -- | -- | 239.00K |
| Total Other Current Liabilities | 260.60K | 248.60K | -- | -- | 239.00K |
| Total Current Liabilities | 3.38M | 3.22M | 1.64M | 1.60M | 1.97M |
|
|
|||||
| Total Current Liabilities | 3.38M | 3.22M | 1.64M | 1.60M | 1.97M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 403.10K | 384.50K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.78M | 3.61M | 1.64M | 1.60M | 1.97M |
|
|
|||||
| Common Stock & APIC | 143.97M | 137.33M | 145.62M | 142.33M | 139.44M |
| Retained Earnings | -116.01M | -110.66M | -110.21M | -107.72M | -98.73M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 27.96M | 26.67M | 35.41M | 34.61M | 40.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.96M | 26.67M | 35.41M | 34.61M | 40.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.96M | 26.67M | 35.41M | 34.61M | 40.70M |
|
|
|||||